Physician profile
Mark Mikhael
NPI 1346446101
$68,333.04
in general payments reported to CMS, 2019-2025
15 companies · $3,545 in 2025
The $3,545 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $16K · 2021: $8,899 · 2022: $2,754 · 2023: $1,232 · 2024: $18K · 2025: $3,545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $2,270 · Travel and Lodging: $1,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,291.68 |
| Food and Beverage | $2,269.67 |
| Travel and Lodging | $1,325.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Orthopaedic Solutions, INC. | $33,153.21 | 2019-2020 | |
| Fusion Orthopedics USA, LLC | $21,049.74 | 2024-2025 | |
| Arthrex, INC. | $8,214.52 | 2021 | |
| Vilex LLC | $2,084.75 | 2022 | |
| Stryker Corporation | $1,698.77 | 2020-2025 | Gamma, Axsos, Variax |
| Kyocera Medical Technologies, INC. | $628.87 | 2023 | |
| Amgen INC. | $489.52 | 2019-2022 | |
| Saxum Surgical, INC. | $372.95 | 2022-2025 | |
| Trimed, INC. | $253.97 | 2022 | |
| Encore Medical, LP | $161.54 | 2021 | |
| Globus Medical, INC. | $91.74 | 2021 | |
| Boston Scientific Corporation | $57.95 | 2023 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $32.13 | 2024 | Eterna |
| Medtronic, INC. | $25.20 | 2025 | Plasmablade(Tm) |
| Endo Pharmaceuticals INC. | $18.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mikhael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.